A case of drug therapy practice of pneumocystis jirovecii pneumonia secondary to COVID-19 in patient with renal insufficiency after renal transplantation
This report is the diagnostic and therapeutic process of a hemodialysis patient after renal transplantation who developed pneumocystis jirovecii pneumonia(PCP)following COVID-19.According to the patient's pathophysiological char-acteristics and laboratory examination results,clinical pharmacists carried out consultations,assisting in formulating the initial treatment plan of sulfamethoxazole-trimethoprim for injection combined with caspofungin,and carried out pharmaceutical care.After the patient's condition improved,clinical pharmacists suggested adjusting the injection form of sulfamethoxazole-trimethoprim to oral form.No serious adverse reactions occurred during the entire PCP treatment process,and finally,the pa-tient was successfully discharged.
NETL
NSTL
万方数据
